0001127602-17-025507.txt : 20170811 0001127602-17-025507.hdr.sgml : 20170811 20170811164102 ACCESSION NUMBER: 0001127602-17-025507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170809 FILED AS OF DATE: 20170811 DATE AS OF CHANGE: 20170811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACKERMANN CHRISTINA CENTRAL INDEX KEY: 0001681871 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 171025683 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-08-09 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001681871 ACKERMANN CHRISTINA 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 EVP AND GENERAL COUNSEL Common Stock, No Par Value 2017-08-09 4 F 0 6046 15.37 D 62373 D This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. /s/ Kelly Webber, attorney-in-fact for Christina Ackermann 2017-08-11